ArticleBritish journal of cancer2024

Dual-modified antisense oligonucleotides targeting oncogenic protocadherin to treat gastric cancer.

Mitsuro Kanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.